2023 Pennsylvania Consolidated & Unconsolidated Statutes › Title 51 - MILITARY AFFAIRS › Chapter 95 - Long-term Care Patient Access to Pharmaceuticals › Section 9505 - Third-party drugs in long-term care facilities, assisted living residences and personal care homes

§ 9505. Third-party drugs in long-term care facilities, assisted living residences and personal care homes.
(a) Authority.--
Notwithstanding any other provision of law, all of the following may dispense a drug acquired from a drug source facility outside the long-term care facility, assisted living residence or personal care home to a patient of a long-term care facility, assisted living residence or personal care home:
(1) A pharmacist employed by a long-term care facility, assisted living residence or personal care home.
(2) A pharmacy that contracts with a long-term care facility, assisted living residence or personal care home to fill prescriptions for patients residing in these settings.
(b) Unit dose.--
A person authorized under subsection (a) to dispense a drug shall repackage, relabel and dispense the drug in a unit dose if all of the following conditions are met:
(1) The drug is obtained from a drug source facility.
(2) There is a prescription for the drug.
(3) The prescriber has signed a form authorizing the long-term care facility, assisted living residence or personal care home to administer a drug from a drug source facility outside the long-term care facility, assisted living residence or personal care home.
(4) The patient has signed a form authorizing the long-term care facility, assisted living residence or personal care home to administer a drug from a drug source facility outside the location and provided payment information for payment of the related fees to the pharmacy. In the case of a minor or a patient who is unable to sign the form, a parent, a guardian, an agent acting under a power of attorney or a family member is authorized to sign the form. The form must explain that a person authorized under subsection (a) to dispense a drug from a drug source facility outside the long-term care facility, assisted living residence or personal care home:
(i) is required to go through the process of repackaging and relabeling the drug;
(ii) may charge a fee for repackaging and relabeling the drug, including the amount of the fee and the frequency of its assessment; and
(iii) has immunity from civil liability arising from dispensation of the drug if the person properly repackages and relabels the drug as set forth in section 9508 (relating to civil liability and unprofessional conduct).
(5) The attending physician or other provider prescribing medications for the patient within their scope of practice has issued an order continuing the patient's medical regime.
(6) The repackaging is in compliance with the Food and Drug Administration, the United States Pharmacopeia and the policies and procedures of the long-term care facility, assisted living residence or personal care home.
(7) The United States Department of Veterans Affairs provides the drug directly to the pharmacy in the long-term care facility, assisted living residence or personal care home in the patient's name or by mailing it to a lockbox located at the long-term care facility, assisted living residence or personal care home in the patient's name and with the following information in preparation for the repackaging and relabeling:
(i) The name and address of the dispensing pharmacy.
(ii) (Reserved).
(iii) (Reserved).
(iv) A copy of the original prescription upon request.
(v) The date the drug was dispensed.
(vi) Directions for use, contraindications and other materials required by law to be provided to the patient.
(7.1) A pharmacist must be held responsible for his activity or activity performed under his supervision or authorization.
(8) The pharmacist manager of the pharmacy, within the long-term care facility, assisted living residence or personal care home or that has a contract with the long-term care facility, assisted living residence or personal care home responsible for access to the lockbox shall be responsible for the following:
(i) Reviewing and approving written policies and procedures for lockbox operation, safety, security, accuracy, access and patient confidentiality.
(ii) Ensuring that medications received at the lockbox are inspected for expiration date, misbranding and physical integrity and ensuring that the lockbox is inspected for security and accountability every month.
(iii) Inspecting medications received at the lockbox to determine if:
(A) the original contents have deteriorated significantly due to heat, cold fermentation or prolonged agitation; or
(B) the sensors indicate the integrity of the drug was compromised if the drugs were shipped in a manner that would preserve the integrity of the drug, such as cold packs or other temperature control devices.
(iv) Assigning, discontinuing or changing authorized personnel access to the lockbox.
(v) Ensuring that an accountability record is maintained in accordance with the written policies and procedures of operation.
(vi) Ensuring compliance with the applicable provisions of Federal and State law.
(Oct. 14, 2014, P.L.2511, No.147, eff. 60 days)
Special Provisions in Appendix.
See section 3(3)(iii) of Act 36 of 2012 in the appendix to this title for special provisions relating to continuation of prior law.
Cross References.
Section 9505 is referred to in sections 9504, 9506, 9507, 9508 of this title.